Hardman & Co Research 
Hardman & Co Research: Yew Grove (YEW): NAV rise validates an excellent strategy 
29-March-2021 / 07:00 GMT/BST 
=---------------------------------------------------------------------------------------------------------------------- 
Hardman & Co Research: NAV rise validates an excellent strategy 
Yew Grove invests in office and industrial assets in the Republic of Ireland (RoI). RoI GDP grew 3.4% in 2020, with 
18.2% gross value added from multinational input. Yew Grove's largest tenant segment is Life Sciences (35%), which 
benefits from Foreign Direct Investment (FDI) and, across the board, this macroeconomic attractiveness is being 
captured by the company. In the past four quarters, Yew Grove has achieved an average 99% rent paid on time. The 
valuation on its offices rose 1.9% 2020 and industrial assets by 5.5%. Two rent rises achieved 24% and 25% uplifts. 
Further reversion potential is evident for both offices and industrials. 
Please click on the link below for the full report: 
https://www.hardmanandco.com/research/corporate-research/nav-rise-validates-an-excellent-strategy/ 
If you are interested in meeting the company, you can register your interest by clicking on the above link 
To contact us: 
Hardman & Co                       Contact: 
1 Frederick's Place 
                                   Mike Foster 
London                                                mf@hardmanandco.com 
EC2R 8AE 
                                   +44(0)20 3693 7075 
www.hardmanandco.com 
Follow us on Twitter @HardmanandCo

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer. -----------------------------------------------------------------------------------------------------------------------

Dissemination of a CORPORATE NEWS, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. -----------------------------------------------------------------------------------------------------------------------

1179097 29-March-2021

(END) Dow Jones Newswires

March 29, 2021 02:00 ET (06:00 GMT)